Cargando…
Transcriptome analysis of endometrial tissues following GnRH agonist treatment in a mouse adenomyosis model
PURPOSE: Adenomyosis is a common, benign gynecological condition of the female reproductive tract characterized by heavy menstrual bleeding and dysmenorrhea. Gonadotropin-releasing hormone (GnRH) agonists are one of the medications used in adenomyosis treatment; however, their underlying mechanisms...
Autores principales: | Guo, Song, Lu, Xiaowei, Gu, Ruihuan, Zhang, Di, Sun, Yijuan, Feng, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352156/ https://www.ncbi.nlm.nih.gov/pubmed/28331289 http://dx.doi.org/10.2147/DDDT.S127889 |
Ejemplares similares
-
GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity
por: Guo, Song, et al.
Publicado: (2018) -
Transcriptome analysis of eutopic endometrium in adenomyosis after GnRH agonist treatment
por: Tian, Jiao, et al.
Publicado: (2022) -
The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
por: Cho-Clark, Madelaine J., et al.
Publicado: (2023) -
Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015) -
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)